Gaps in Treatment and Surveillance: Head and Neck Cancer Care in a Safety-Net Hospital
- PMID: 32083239
- PMCID: PMC7005972
- DOI: 10.1177/2473974X19900761
Gaps in Treatment and Surveillance: Head and Neck Cancer Care in a Safety-Net Hospital
Abstract
Objective: Treatment delays and suboptimal adherence to posttreatment surveillance may adversely affect head and neck cancer (HNC) outcomes. Such challenges can be exacerbated in safety-net settings that struggle with limited resources and serve a disproportionate number of patients vulnerable to gaps in care. This study aims to characterize treatment delays and adherence with posttreatment surveillance in HNC care at an urban tertiary care public hospital in San Francisco.
Study design: Retrospective chart review.
Setting: Urban tertiary care public hospital in San Francisco.
Subjects and methods: We identified all cases of HNC diagnosed from 2008 to 2010 through the electronic medical record. We abstracted data, including patient characteristics, disease characteristics, pathology and radiology findings, treatment details, posttreatment follow-up, and clinical outcomes.
Results: We included 64 patients. Median time from diagnosis to treatment initiation (DTI) was 57 days for all patients, 54 days for patients undergoing surgery only, 49 days for patients undergoing surgery followed by adjuvant radiation ± chemotherapy, 65 days for patients undergoing definitive radiation ± chemotherapy, and 29 days for patients undergoing neoadjuvant chemotherapy followed by radiation or chemoradiation. Overall, 69% of patients completed recommended treatment. Forty-two of 61 (69%) patients demonstrated adherence to posttreatment visits in year 1; this fell to 14 out of 30 patients (47%) by year 5.
Conclusion: DTI was persistently prolonged in this study compared with prior studies in other public hospital settings. Adherence to posttreatment surveillance was suboptimal and continued to decline as the surveillance period progressed.
Keywords: delay to treatment initiation; head and neck cancer; monitoring; public hospital; safety-net hospital; surveillance.
© The Authors 2020.
Similar articles
-
Disparities in head and neck cancer: assessing delay in treatment initiation.Laryngoscope. 2012 Aug;122(8):1756-60. doi: 10.1002/lary.23357. Epub 2012 May 8. Laryngoscope. 2012. PMID: 22570084
-
Outcomes of men on active surveillance for low-risk prostate cancer at a safety-net hospital.Urol Oncol. 2017 Nov;35(11):663.e9-663.e14. doi: 10.1016/j.urolonc.2017.07.003. Epub 2017 Aug 18. Urol Oncol. 2017. PMID: 28826701
-
An electronic registry to improve adherence to active surveillance monitoring among men with prostate cancer at a safety-net hospital: protocol for a pilot study.Pilot Feasibility Stud. 2019 Aug 14;5:101. doi: 10.1186/s40814-019-0482-x. eCollection 2019. Pilot Feasibility Stud. 2019. PMID: 31428442 Free PMC article.
-
Electronic self-reporting of adverse events for patients undergoing cancer treatment: the eRAPID research programme including two RCTs.Southampton (UK): NIHR Journals Library; 2022 Feb. Southampton (UK): NIHR Journals Library; 2022 Feb. PMID: 35138783 Free Books & Documents. Review.
-
Adherence to nutritional interventions in head and neck cancer patients: a systematic scoping review of the literature.J Hum Nutr Diet. 2021 Jun;34(3):562-571. doi: 10.1111/jhn.12848. Epub 2020 Dec 12. J Hum Nutr Diet. 2021. PMID: 33314352 Review.
Cited by
-
Regarding "Gaps in Treatment and Surveillance: Head and Neck Cancer Care in a Safety-Net Hospital".OTO Open. 2020 Jul 6;4(3):2473974X20938658. doi: 10.1177/2473974X20938658. eCollection 2020 Jul-Sep. OTO Open. 2020. PMID: 32671319 Free PMC article. No abstract available.
References
-
- Ridge JA, Mehra R, Lango M, Galloway T. Head and neck tumors Cancer Network. https://www.cancernetwork.com/cancer-management/head-and-neck-tumors. Published June 2016. Accessed September 17, 2016.
-
- Gourin CG, Podolsky RH. Racial disparities in patients with head and neck squamous cell carcinoma. Laryngoscope. 2006;116:1093-1106. - PubMed
-
- Thomas K, Martin T, Gao A, Ahn C, Wilhelm H, Schwartz DL. Interruptions of head and neck radiotherapy across insured and indigent patient populations. J Oncol Pract. 2017;13:319-328. - PubMed
-
- Charlson ME, Pompei P, Ales KL, MacKenzie CR. New method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383. - PubMed
-
- National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Head and Neck Cancers Version I.2018. https://oncolife.com.ua/doc/nccn/Head_and_Neck_Cancers.pdf. Published February 2018. Accessed December 3, 2018.
Grants and funding
LinkOut - more resources
Full Text Sources
